BriaCell Therapeutics Corp. Warrant
NASDAQ: BCTXZ0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Select
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- William V. Williams
- Employees
- 16
- Headquarters
- West Vancouver, Canada
- IPO year
- 2025
- Market cap
- $149.0K
- Website
- https://www.briacell.com
Loading BCTXZ…
Loading profile data…Frequently asked questions about BCTXZ
What does BriaCell Therapeutics Corp. Warrant (BCTXZ) do?
BriaCell Therapeutics Corp., a biotechnology company based in West Vancouver, Canada, is intensely focused on immuno-oncology, dedicated to engineering novel immunotherapies for cancer treatment. Its flagship compound, Bria-IMT, is a whole-cell cancer vaccine presently in Phase I/IIa clinical development, where it's being evaluated in conjunctio...
Where does BCTXZ trade?
BriaCell Therapeutics Corp. Warrant (BCTXZ) trades on the NASDAQ Global Select.
What sector is BCTXZ in?
BriaCell Therapeutics Corp. Warrant (BCTXZ) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of BriaCell Therapeutics Corp. Warrant?
William V. Williams is the chief executive officer of BriaCell Therapeutics Corp. Warrant (BCTXZ).
Where is BriaCell Therapeutics Corp. Warrant headquartered?
BriaCell Therapeutics Corp. Warrant is headquartered in Canada.
Does BCTXZ pay a dividend?
BriaCell Therapeutics Corp. Warrant (BCTXZ) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did BCTXZ go public?
BriaCell Therapeutics Corp. Warrant (BCTXZ) completed its initial public offering in 2025.